Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Akeso, Inc. ( (HK:9926) ) is now available.
Akeso, Inc. has announced that its board of directors will meet on August 26, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is crucial as it will determine the company’s financial performance and strategic direction, impacting stakeholders and potentially influencing its market position.
The most recent analyst rating on (HK:9926) stock is a Buy with a HK$58.97 price target. To see the full list of analyst forecasts on Akeso, Inc. stock, see the HK:9926 Stock Forecast page.
More about Akeso, Inc.
Akeso, Inc. is a company incorporated in the Cayman Islands, operating in the healthcare industry. It focuses on the development and commercialization of innovative therapies and pharmaceutical products.
Average Trading Volume: 12,794,967
Technical Sentiment Signal: Buy
Current Market Cap: HK$140.5B
For detailed information about 9926 stock, go to TipRanks’ Stock Analysis page.